Tech giants have seized a huge share of the health and preventive technology market, but how could partnerships between the pharmaceutical and tech industries benefit patients and healthcare systems?

To do well at digital transformation, pharma leaders must balance skills development with maintaining employee morale.

Christine Miller is the President, Chief Executive Officer, and member of the board, Melinta Therapeutics, speaks to us about her path into the pharmaceutical industry, her mission to end antimicrobial resistance, and how to be an effective leader in pharma today

Amidst an ever-changing launch landscape, the COVID-19 pandemic has entirely disrupted the pharmaceutical industry, encouraging adaptation for success. By understanding the transformed patient journey, leveraging digital campaigns, and innovating in healthcare marketing strategies, how can pharma find new avenues for launch success?

Social justice is a rising priority for all industries, but particularly for the pharmaceutical sector in the wake of COVID-19 and the social inequities it unveiled. We look at how the industry is increasingly working alongside the world’s top advertising agencies to promote growth from good in their activities.

Neurological conditions are complex and require a high level of expertise and sensitivity, making them an juicy area for medical affairs teams. How do the challenges shape the MA role in this space and how is the landscape evolving?

As the pharmaceutical industry transitions from the Trump to the Biden era, what regulatory changes can be expected and how will a new approach to healthcare policy affect the sector? 

Addressing global access to medicine, particularly in LMICs, poses a significant challenge. As COVID-19 vaccines are distributed, how can the pharmaceutical industry ensure they reach vulnerable populations in these countries while protecting patent rights?